12,231 Followers on Owler

PerkinElmer

Read more
Prahlad Singh's photo - President & CEO of PerkinElmer

President & CEO

Prahlad Singh

CEO Approval Rating

84/100

Founded:

1937

Status:

PublicIndependent CompanyNYSEPKI

PERKINELMER TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

PerkinElmer's company profile
Prahlad Singh's photo - President & CEO of PerkinElmer

Prahlad Singh

President & CEO

84/100
12,500
$500M
$4.9B
View Profile
1
PerkinElmer's Competitor - Agilent logo
Michael McMullen's photo - President & CEO of Agilent

Michael McMullen

President & CEO

93/100
14,800
$2.2B
$5.3B
View Profile
2
PerkinElmer's Competitor - Thermo Fisher logo
Marc N. Casper's photo - President & CEO of Thermo Fisher

Marc N. Casper

President & CEO

88/100
70,000
$3.1B
$38.3B
View Profile
3
PerkinElmer's Competitor - Waters logo
Udit Batra's photo - President & CEO of Waters

Udit Batra

President & CEO

82/100
7,200
- -
$2.7B
View Profile
4
PerkinElmer's Competitor - Bruker logo
Frank H. Laukien's photo - Chairman & CEO of Bruker

Frank H. Laukien

Chairman & CEO

71/100
6,870
$106M
$2.3B
View Profile
5
PerkinElmer's Competitor - Harvard Bioscience logo
James Green's photo - Chairman & CEO of Harvard Bioscience

James Green

Chairman & CEO

65/100
519
$122.5M
$111.2M
View Profile
6
PerkinElmer's Competitor - QIAGEN logo
Thierry Bernard's photo - CEO of QIAGEN

Thierry Bernard

CEO

70/100
5,610
$487.1M
$2.1B
View Profile
7
PerkinElmer's Competitor - Bio-Rad logo
Norman Schwartz's photo - Chairman & CEO of Bio-Rad

Norman Schwartz

Chairman & CEO

82/100
8,250
- -
$2.9B
View Profile
8
PerkinElmer's Competitor - Misonix logo
Stavros G. Vizirgianakis's photo - President & CEO of Misonix

Stavros G. Vizirgianakis

President & CEO

85/100
118
$10.2M
$74M
View Profile
9
PerkinElmer's Competitor - Mettler Toledo logo
Patrick Kaltenbach's photo - President & CEO of Mettler Toledo

Patrick Kaltenbach

President & CEO

98/100
16,000
$93.3M
$3.5B
View Profile
10
PerkinElmer's Competitor - Kewaunee logo
Thomas D Hull's photo - President & CEO of Kewaunee

Thomas D Hull

President & CEO

75/100
856
$8M
$150.5M
View Profile
11
PerkinElmer's Competitor - Beckman Coulter logo
Julie Sawyer Montgomery's photo - President of Beckman Coulter

Julie Sawyer Montgomery

President

83/100
11,000
$1.3M
$2.1B
View Profile
12
PerkinElmer's Competitor - Illumina logo
Francis DeSouza's photo - President & CEO of Illumina

Francis DeSouza

President & CEO

65/100
7,300
$96M
$4B
View Profile

Missing a competitor? Contribute!

Agilent has been one of PerkinElmer's top competitors. Agilent is a Public company that was founded in 1999 in Santa Clara, California. Agilent operates in the Health Care Equipment industry. Compared to PerkinElmer, Agilent has 4,200 more employees.

Thermo Fisher is seen as one of PerkinElmer's biggest rivals. Thermo Fisher is a Public company that was founded in Waltham, Massachusetts in 1956. Thermo Fisher is in the Health Care Equipment industry. Thermo Fisher has 67,500 more employees vs. PerkinElmer.

Waters is perceived as one of PerkinElmer's biggest rivals. Waters was founded in Milford, Massachusetts} in 1958. Waters competes in the Health Care Equipment industry. Compared to PerkinElmer, Waters generates $2.2B less revenue.

PerkinElmer Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$4.9B

PerkinElmer's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 7.3B. Over the last four quarters, PerkinElmer's revenue has grown by 27.4%. Specifically, in Q3 2021's revenue was $1.2B; in Q2 2021, it was $1.3B; in Q1 2021, it was $1.4B; in Q4 2020, PerkinElmer's revenue was $964M.

PerkinElmer Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
BioLegend, Inc.

Jul 2021

Source »
$5.3B
BioLegend is a California-based developer and manufacturer of products such as antibodies and reagents for the life sciences industry.
SIRION Biotech GmbH

Jun 2021

Source »
$260M
SIRION Biotech is a Germany-based company that designs and supplies viral vectors for genetic cell modeling, target validation, and preclinical development.
Immunodiagnostic Systems Holdings PLC

May 2021

Source »
$155M
IDS is an England-based biotechnology company that develops and commercializes in-vitro diagnostic immunoassays and related products for the healthcare sector.
Nexcelom Bioscience, LLC

May 2021

Source »
$260M
Nexcelom is a Massachusetts-based developer and marketer of automated cell counters, image cytometers, and related items for life science and biomedical research applications.
ES Industries, Inc.

Mar 2021

Source »
undisclosed
ES Industries is a New Jersey-based company that provides HPLC and SFC chromatographers for purification column repacking and chiral and achiral purification service.

These are all the companies that PerkinElmer has acquired. PerkinElmer has acquired 14 companies and its latest acquisition was BioLegend, Inc. in Jul 2021. BioLegend is a California-based developer and manufacturer of products such as antibodies and reagents for the life sciences industry.

PerkinElmer Funding History

Since PerkinElmer was founded in 1937, it has participated in 1 round of funding. In total PerkinElmer has raised $500.0M. PerkinElmer's funding round was on Sep 2021 for a total of $500.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Post-IPO Debt
Sep 2021
$500M
-

Since PerkinElmer was founded in 1937, it has participated in 1 round of funding. In total PerkinElmer has raised $500.0M. PerkinElmer's funding round was on Sep 2021 for a total of $500.0M

PerkinElmer Investments

No recent investments found related to PerkinElmer

PerkinElmer News

September 20, 2021The Business Journals

Mass. Covid-19 test makers poised to meet demand following Biden order

Local diagnostic makers like PerkinElmer Inc. and Eurofins Inc. have spent the last year and a half s... See more »
August 31, 2021Lab Bulletin

PerkinElmer's COVID-19 RT-PCR Test Kit Receives FDA Emergency Use Authorization for Saliva as Specimen Type

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that ... See more »
August 26, 2021Benzinga

PerkinElmer Announces $1.5B Credit Facility Deal

PerkinElmer Inc (NYSE: PKI) has agreed to a new $1.5 billion revolving credit facility. The agreement... See more »
August 12, 2021Genomeweb

PerkinElmer Enters $500M Credit Facility

The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced l... See more »
August 1, 2021San Diego Business Journal

BioLegend to Be Acquired for $5.25 Billion

BioLegend, a global developer and manufacturer of antibodies and reagents, agreed to be acquired by P... See more »

PerkinElmer Press Releases

May 4, 2021Business Wire

PerkinElmer to Host Virtual Investor and Analyst Day

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovati... See more »
April 22, 2021Business Wire

PerkinElmer Supports PROXIDRUGS Consortium Aimed at Advancing Targeted Protein Degradation/PROTAC Drugs

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. is supporting the PROXIDRUGS Consortium studying t... See more »
April 21, 2021Business Wire

PerkinElmer to Present at BofA Securities 2021 Virtual Health Care Conference

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovati... See more »
April 13, 2021Business Wire

PerkinElmer Provides First Quarter Update and Schedules Earnings Call for Tuesday, May 4, 2021

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovati... See more »
March 18, 2021Business Wire

PerkinElmer Launches Industry-First CRM Reagent and Consumable Kit to Streamline Cannabis Pesticide Testing Workflows

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. today launched its ONE Pesticide420 CRM Reagent an... See more »
February 22, 2021Business Wire

PerkinElmer Provides an Update on Valencia Branch Laboratory's Accreditation Process

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovati... See more »
February 9, 2021centralcharts

Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oxford Immunotec Global PLC - OXFD

OXFORD IMMUNOTEC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC I... See more »

PerkinElmer Videos

Social Media

PerkinElmer Headquarters

940 Winter Street

Waltham, Massachusetts02451

1-781-663-6900

Driving Directions »

Trending Companies

PerkinElmer Summary

ABOUT

Overview

Perkinelmer is a Massachusetts-based company that offers solutions including drug research, medical imaging and genetic testing for industries such as food and health. PerkinElmer was founded in 1937. PerkinElmer's headquarters is located in Waltham, ...

CEO

PerkinElmer's President & CEO, Prahlad Singh, currently has an approval rating of 84%. PerkinElmer's primary competitors are Agilent, Thermo Fisher & Waters.

Frequently Asked Questions about PerkinElmer

  1. When was PerkinElmer founded?

    PerkinElmer was founded in 1937
  2. Who is PerkinElmer's CEO?

    PerkinElmer's CEO is Prahlad Singh
  3. How much revenue does PerkinElmer generate?

    PerkinElmer generates $4.9B in revenue
  4. How much funding does PerkinElmer have?

    PerkinElmer has historically raised $500M in funding
  1. Where is PerkinElmer's headquarters?

    PerkinElmer's headquarters is in Waltham Massachusetts, USA
  2. How many employees does PerkinElmer have?

    PerkinElmer has 12,500 employees
  3. What sector does PerkinElmer operate in?

    PerkinElmer is in Health Care Services
  4. Who are PerkinElmer's competitors?

    PerkinElmer's top competitors are Agilent, Thermo Fisher, Waters